Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin

International Journal of STD and AIDS

Volumn 8, Issue 5, 1997, Pages 299-302

  Young, H ^a   Moyes, A ^a   McMillan, A ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Antibiotics; Azithromycin; Erythromycin; Neisseria gonorrhoeae; Resistance

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG RESISTANCE; GONORRHEA; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 0030920167     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971920127     Document Type: Article

References (21)

1. Mehaffey PC, Putnam SD, Barret MS, Jones RN. Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and E test methods. J Clin Microbiol 1996;34:479-81
2. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992; 327:921-5
3. Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Single dose azithromycin treatment of gonorrhoea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994;21:43-6
4. Stamm WE, Hicks CB, Martin DH, et al. Azithromycin for empirical treatment of the non-gonococcal urethritis syndrome in men: a randomized double blind study. JAMA 1995;274:545-9
5. Lewis DA, Ison CA, Livermore DM, Chen HY, Hooi AY, Wisdom AR. A one-year study of Neisseria gonorrhoeae isolated from patients attending an East London genitourinary medicine clinic: antibiotic susceptibility patterns and patients' characteristics. Genitourin Med 1995;71:13-17
6. Chevalier B, Crenn Y, Cavallo JD, Plotton N, Meyran M. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae. Pathol Biol 1995;43:281-3
7. Handsfield HH, Dalu ZA, Martin DH, et al. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhoea. Sex Transm Dis 1994;21:107-11
8. Waugh MA. Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women. J Antimicrob Chemother 1993;31(suppl E):193-8
9. Ehret JM, Nims LJ, Judson FN. A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. Sex Transm Dis 1996;23:270-2
10. Young H, Moyes A, Robertson DHH, et al. Gonococcal infection within Scotland: antigenic heterogeneity and antibiotic susceptibility of infecting strains. Eur J Epidemiol 1990;6:1-8
11. Moyes A, Young H. Typing of Neisseria gonorrhoeae by auxotype, serovar and lectin agglutination. Br J Biomed Sci 1993;50:295-300
12. Lind I, Riou JY, Sng EH, Bentzon MW. Antimicrobial susceptibility testing of Neisseria gonorrhoeae: guidelines for use of the WHO Reference Strains. Copenhagen: WHO Collaborating Centre for Reference and Research in Gonococci, Statens Seruminstitut, 1984
13. Jones RN, Gavan TL, Thornsberry C, et al. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol 1989;27:2758-66
14. Ringertz S, Rylander M, Kronvall G. Disk diffusion method for susceptibility testing of Neisaeria gonorrhoeae. J Clin Microbiol 1991;29:1604-9
15. Turner A, Jephcott AE, Gough KR. Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae. J Clin Pathol 1991;44:169-70
16. Young H, Moyes A. Gonococcal infections in Scotland, 1995. Scot Centre Infect Environmental Health Weekly Report 1996;30:234-8
17. Slaney L, Chubb H, Ronald A, Brunham R. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoea, Haemophilia ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother 1990;25(suppl A):1-5
18. Vanrijsoortvos JH, Stolz E, Verbrugh HA, Kluytmans JAJW. In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae. J Antimicrob Chemother 1995;36:215-18
19. Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995;20:S47-S65
20. Bignell C. Antibiotic treatment of gonorrhoea - clinical evidence for choice. Genitourin Med 1996;72:315-20
21. Handsfield HH. Antibiotic resistant Neisseria gonorrhoeae: the calm before another storm? Ann Intern Med 1996;125:507-9